Syngene International Limited
Syngene International Limited is an Indian listed company in the Healthcare Services industry (Healthcare sector), traded under NSE: SYNGENE and BSE: 539268 (ISIN INE398R01022).
It has a market capitalisation of ₹16,015 crore, a last close of ₹397.50 on 2026-10-19, a one-year return of -37.8%.
Valuation: a price-to-earnings ratio of 72.47x, a price-to-book ratio of 3.31x, a dividend yield of 0.3%.
Profitability: return on equity of 0.0%, return on capital employed of 8.4%, an operating margin of 22.3%.
Growth: sales growth of 5.4% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 52.6%.
| Metric | Value |
|---|---|
| Market capitalisation | 16,015 |
| Last close | ₹397.50 |
| P/E (TTM) | 72.47x |
| P/B | 3.31x |
| Dividend yield | 0.3% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 8.4% |
| Operating margin (TTM) | 22.3% |
| Sales growth, 3-year CAGR | 5.4% |
| Debt / equity | 0.00x |
| Promoter holding | 52.6% |
| 1-year return | -37.8% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means